Myeloid lineage switch in KMT2A- rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies

Haematologica. 2024 Jan 1;109(1):293-297. doi: 10.3324/haematol.2023.283705.

Affiliations

¹ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
² Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
³ Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
⁴ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. ksasaki1@mdanderson.org.

No abstract available

MeSH terms

Cell Lineage / genetics
Gene Rearrangement
Humans
Leukemia, Myeloid, Acute* / genetics
Myeloid-Lymphoid Leukemia Protein / genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics

Substances

Myeloid-Lymphoid Leukemia Protein